Reneuron Share Discussion Threads

[dickbush] 15/10/2019 17:31

Interesting. I note that Arix has an association with Sir Chris Evans, who is on Reneuron's Board, and also has a connection with Fosun. Last reported cash balance was £60mil with £13.5 mil committed to future investment. I wonder...

At the current discount to NAV, it would make sense for Arix to buy Woodford's 5% holding.

[hashertu] 15/10/2019 16:57

For info.
Woodford IM holding RNS in Arix.
July 20%, today less than 5%.
Arix share price has dropped from 170 to 110p approx, this year.
How much is due to the Woodford effect is debatable, but probably significant.

[dickbush] 15/10/2019 16:54

It looks like Woodford's whole holding is up for grabs.



and

[dickbush] 15/10/2019 16:24

I see that Sterling is rising against both the Euro and the Dollar as a deal with Europe seems to be happening. That's another variable that, no doubt, is producing some reluctance by potential foreign buyers of UK companies. Who wants to be the CEO who makes a purchase and sees Sterling drop substantially immediately afterwards?

[rrb] 15/10/2019 15:21

I think a deal is better for shareholders as it keeps company independent and, depending on size of deal and the mechanics, probably draws a line under funding uncertainty in the medium term. It also further validates the pipeline potential. An outright takeover would, from these levels, probably undervalue the upside significantly. But as I said before, even £200-300m is nothing for a US biotech or pharma company looking to acquire this IP.

[dickbush] 15/10/2019 14:23

Many thanks, rrb. I guess we just have to wait and watch for developments. I'm still thinking in terms of a bid, probably by a US company in a related field, but I'll be delighted if, instead, we get a substantial deal like Fosun's. I'd prefer to see this through to product sales and profits rolling in. I don't think a bid would be in our best interests.

[bull16] 15/10/2019 12:32

See Bullet Pants is having some of his posts deleted.

They are onto you.

Pretty soon 5 o will come knocking...so you'd best clean up that hard drive and get rid of all those things that will send you straight to the Big House.

[dickbush] 15/10/2019 09:54

Both own the shares but only Equity Income is being liquidated. No idea how many are owned by each of his funds.

[hashertu] 15/10/2019 09:48

Which Woodfood entity owns the RENE shares?
Is it Income, Equity/Income or WPCT?
As I understand it, only the Equity/income fund is being wound up.
If the shares are held by WCPT, then is there any pressing need to sell?
The shareholding RNS cites Woodfood Asset Management.

[dickbush] 15/10/2019 09:40

The more I think about it the more it seems to me that Reneuron's days as an independent company are numbered. I'm very disappointed as I thought the trial results from both products would be good enough to see big profits rolling in after 2021. Getting from here to there, though, now seems impossible. Anyone see a more optimistic future?

[rrb] 15/10/2019 09:11

BADG - yes. Has been overhang for a while. Woodford owns 33%. They have to find a buyer for the lot. But at these levels, £10-12m is a cheap option relative to upside.

[badg] 15/10/2019 08:52

Is this a N Woodford reaction too?

[eggy6198] 15/10/2019 08:46

Chung your pushing of pervian cook books is very passionate

[dickbush] 15/10/2019 08:42

No argument from me that they need substantial funding to do the Phase 2b stroke trial, and similar for a Phase 2b RP trial. They warned us that would need funding again in the near future and Woodford was a hindrance to fund-raising. Once this hiatus is past (? over the next couple of months as the administrator flogs everything off cheaply) the shares should be valued on their merits, including the knowledge that they need to raise a LOT of money.

Worst case, they get taken out by a bigger pharma company in a related area at a knock-down, but substantially higher than this, price. Don't forget that the Chairman has a record of selling small biotech companies to bigger ones, and he bought 80,000 at 225p just a few months ago.

A tough day at the office for the Directors today. They are definitely between a rock and a hard place.

[ken chung] 15/10/2019 08:16

Down 10% now.50p soon.Lemmings and mushrooms only.

[hollywood6] 15/10/2019 08:16

Reneuron have said they need funds. Either via partnership deals or they will go to the market

[dickbush] 15/10/2019 08:15

Reason for price collapse is Woodford has gone from an obstacle to fund raising to a forced seller. It has nothing to do with changed fundamentals of the company.



Anyone's guess what will happen to his shares, but this situation will get sorted out. Just a matter of time.

[ken chung] 15/10/2019 08:12

It's a fools share.Worthless.Lemmings and mushrooms only.

[icejelly] 15/10/2019 08:12

Keep spouting your rubbish then.